DAFTAR PUSTAKA

1. Karyanti, Mulya Rahma. Diagnosis dan tata laksana terkini dengue. Divisi
Infeksi dan Pediatri Tropik, Departemen Ilmu Kesehatan Anak, RSUPN Cipto
Mangunkusumo, FKUI. 2011
2. World Health Organization. Comprehensive Guidelines for Prevention and
Control of Dengue and Dengue Haemorrhagic Fever. 2011
3. Avirutnan P, Punyadee N, Noisakran S, et al. Vascular leakage in severe
Dengue virus infections: a potential role for the nonstructural viral protein
NS-1 and complement. J. Infect.Dis. 2006; 193: 1078-1088.
4. Rizal. Kebocoran Plasma pada Demam Berdarah Dengue. RS Dr. Oen Solo
Baru, Sukoharjo, Jawa Tengah, Indonesia. CDK 183/Vol.38 no.2/Maret - April
2011
5. Darwis, Darlan. Kegawatan Demam Berdarah Dengue pada Anak. Sari
Pediatri, Vol. 4, No. 4, Maret 2003, 156 162
6. Candra, Aryu. Demam Berdarah Dengue: Epidemiologi, Patogenesis, dan
Faktor Risiko Penularan. FK Undip Semarang. Aspirator Vol. 2 No. 2 Tahun
2010 : 110 119
7. Wilder-Smith A, Gubler D. Geographic Expansion of Dengue: the Impact of
International Travel. Med Clin NAm. 2008, Vol. 92: p. 1377-90.

8. Knowlton K, Solomon G, Rotkin-Ellman M, Pitch F. Mosquito-Borne Dengue Fever

Threat Spreading in the Americas. New York: Natural Resources Defense Council
Issue Paper; 2009.

9. U.S.D.T. International Travel and Transportation Trends. Washington D. C.: Bureau

of Transportation Statistics of U.S. Department of Transportation; 2006.

10. Roose A. Hubungan Sosiodemografi dan Lingkungan dengan Kejadian Penyakit

Demam Berdarah Dengue (DBD) di Kecamatan Bukit Raya Kota Pekanbaru. Medan:
Universitas Sumatera Utara; 2008.
11. World Health Organization. Handbook for Clinical Management of Dengue.

2012

12. Srikiatkhachorn A. Plasma leakage in dengue haemorrhagic fever. Thromb

Haemost 2009; 102: 1042-1049

13. Monath TP. Dengue and Yellow Fever Challenges for the Development and

Use of Vaccines. N Engl J Med 2007.357: 2222-2225

14. Depkes RI, 2012. Profil data kesehatan Indonesia tahun 2011. Jakarta: Depkes

RI (Diakses tanggal 28 Oktober 2012).

15. WHO. Dengue: Guidlines for Diagnosis, Treatment, Prevention and Control. New
Edition. Geneva: World Health Organization; 2009.
16. Soegijanto S. Patogenesa dan Perubahan Patofisiologi Infeksi Virus Dengue.
www.pediatrikcom/buletin/20060220-8ma2gi-buletindoc; 2002 [cited 2010];
Available from: www.pediatrikcom/ buletin/20060220-8ma2gi-buletindoc.
17. Koraka P, Suharti C, Setiati CE, Mairuhu AT, Van Gorp E, Hack CE, et al. Kinetics of
Dengue Virus-specific Immunoglobulin Classes and Subclasses Correlate with
Clinical Outcome of Infection. J Clin Microbio. 2001;Vol. 39 4332-8.

18. Lin CF, Wan SW, Chen MC, et al. Liver injury caused by antibodies against
dengue virus nonstructural protein 1 in a murine model. Lab Invest 2008; 88:
1079-1089
19. Cabello-Gutierrez C, Manjarrez-Zavala ME, Huerta- Zepeda A, et al.
Modification of the cytoprotective protein C pathway during Dengue virus
infection of human endothelial vascular cells. Thromb Haemost 2009; 101:
916-928.
20. Lee WL, Slutsky AS. Sepsis and Endothelial Permeability. N Engl J Med
2010. 363: 689-691
21. Dejana, E. Orsenigo F, Lampugnan MG. The Role Aherens Junctions and
Vecadherin in Control of Vascular permeability. JCS 2008; 121(13): 21152122
22. Lee YR, Liu MT, Lei HY, et al. MCP-1, a highly expressed chemokine in
Dengue haemorrhagic fever/ Dengue shock syndrome patients, may cause
permeability change, possibly through reduced tight junctions of vascular
endothelium cells. J Gen Virol 2006; 87: 3623-3630.

23. Avirutnan P, Punyadee N, Noisakran S, et al. Vascular leakage in severe

Dengue virus infections: a potential role for the nonstructural viral protein
NS1 and\complement. J.Infect.Dis. 2006; 193: 1078-1088.